Simplicity Wealth LLC acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) during the second quarter, Holdings Channel reports. The fund acquired 8,380 shares of the company’s stock, valued at approximately $576,000.
Several other hedge funds have also bought and sold shares of USPH. Bank of America Corp DE increased its position in shares of U.S. Physical Therapy by 77.2% during the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after acquiring an additional 138,194 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in U.S. Physical Therapy during the second quarter worth $9,087,000. Schroder Investment Management Group raised its stake in shares of U.S. Physical Therapy by 45.9% during the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after purchasing an additional 114,618 shares during the period. 4D Advisors LLC bought a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at approximately $9,344,000. Finally, First Trust Advisors LP grew its stake in shares of U.S. Physical Therapy by 607.2% during the 4th quarter. First Trust Advisors LP now owns 69,834 shares of the company’s stock worth $5,453,000 after acquiring an additional 59,959 shares during the period.
Analyst Ratings Changes
USPH has been the topic of several analyst reports. Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Citigroup reiterated an “outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, August 10th. Barrington Research increased their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Finally, Citizens Jmp restated a “market outperform” rating and set a $98.00 price target on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $99.50.
Insider Activity
In other U.S. Physical Therapy news, Director Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, June 8th. The shares were bought at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the acquisition, the director directly owned 2,923 shares in the company, valued at approximately $184,558.22. This trade represents a 20.24% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.40% of the stock is owned by insiders.
U.S. Physical Therapy Stock Down 3.6%
Shares of U.S. Physical Therapy stock opened at $78.34 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27. U.S. Physical Therapy, Inc. has a 52-week low of $58.19 and a 52-week high of $93.50. The company’s 50 day moving average price is $72.43 and its 200-day moving average price is $73.96. The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of 460.85, a P/E/G ratio of 2.23 and a beta of 1.13.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm had revenue of $214.06 million for the quarter, compared to the consensus estimate of $211.36 million. During the same quarter in the prior year, the company earned $0.81 earnings per share. The company’s quarterly revenue was up 8.5% compared to the same quarter last year. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.96 EPS for the current year.
U.S. Physical Therapy Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be paid a $0.46 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $1.84 annualized dividend and a dividend yield of 2.3%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 1,082.35%.
U.S. Physical Therapy Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
